Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose–response trial | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

PDF +
Supplementary
Material

Interstitial lung disease

Original research

Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose–response trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: West A, Chaudhuri N, Barczyk A, et al

Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose–response trial

Thorax 2023;78:882-889.